154 related articles for article (PubMed ID: 8182625)
1. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Anaya JM; Fabre D; Bressolle F; Bologna C; Alric R; Cocciglio M; Dropsy R; Sany J
J Rheumatol; 1994 Feb; 21(2):203-8. PubMed ID: 8182625
[TBL] [Abstract][Full Text] [Related]
2. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.
Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
J Rheumatol; 1996 Jun; 23(6):984-9. PubMed ID: 8782127
[TBL] [Abstract][Full Text] [Related]
3. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
Fox RI; Morgan SL; Smith HT; Robbins BA; Choc MG; Baggott JE
Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
[TBL] [Abstract][Full Text] [Related]
4. Folic acid alters methotrexate availability in patients with rheumatoid arthritis.
Bressolle F; Kinowski JM; Morel J; Pouly B; Sany J; Combe B
J Rheumatol; 2000 Sep; 27(9):2110-4. PubMed ID: 10990220
[TBL] [Abstract][Full Text] [Related]
5. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
[TBL] [Abstract][Full Text] [Related]
6. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
Carmichael SJ; Beal J; Day RO; Tett SE
J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
[TBL] [Abstract][Full Text] [Related]
8. Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients.
Bressolle F; Bologna C; Kinowski JM; Arcos B; Sany J; Combe B
J Rheumatol; 1997 Oct; 24(10):1903-9. PubMed ID: 9330930
[TBL] [Abstract][Full Text] [Related]
9. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
Monjanel-Mouterde S; Lafforgue P; Blanc A; Catalin J; Aquaviva PC; Durand A
J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
[TBL] [Abstract][Full Text] [Related]
10. Is there an optimal time to administer methotrexate in the treatment of rheumatoid arthritis?
Carpentier N; Bertin P; Marquet P; Sabot C; Bonnet C; Debord J; Lachâtre G; Trèves R
J Rheumatol; 1998 Jul; 25(7):1270-5. PubMed ID: 9676755
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of an easily prepared solution of injectable methotrexate diluted in water: A comparison of serum concentrations vs methotrexate tablets and clinical utility.
Marshall PS; Gertner E
J Rheumatol; 1996 Mar; 23(3):455-8. PubMed ID: 8832982
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
13. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
[TBL] [Abstract][Full Text] [Related]
14. Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients.
Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
J Rheumatol; 1993 Feb; 20(2):263-7. PubMed ID: 8474062
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
Ahern M; Booth J; Loxton A; McCarthy P; Meffin P; Kevat S
J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Karim A; Tolbert DS; Hunt TL; Hubbard RC; Harper KM; Geis GS
J Rheumatol; 1999 Dec; 26(12):2539-43. PubMed ID: 10606360
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis.
Dalrymple JM; Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Barclay ML
Arthritis Rheum; 2008 Nov; 58(11):3299-308. PubMed ID: 18975321
[TBL] [Abstract][Full Text] [Related]
19. Patients with rheumatoid arthritis treated with methotrexate (MTX): concentrations of steady-state erythrocyte MTX correlate to plasma concentrations and clinical efficacy.
Hornung N; Ellingsen T; Attermann J; Stengaard-Pedersen K; Poulsen JH
J Rheumatol; 2008 Sep; 35(9):1709-15. PubMed ID: 18634162
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate pharmacokinetics in patients with rheumatoid arthritis.
Sinnett MJ; Groff GD; Raddatz DA; Franck WA; Bertino JS
J Rheumatol; 1989 Jun; 16(6):745-8. PubMed ID: 2674426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
